119 related articles for article (PubMed ID: 9118038)
1. The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia.
Iwama H; Ohyashiki K; Ohyashiki JH; Hayashi S; Kawakubo K; Shay JW; Toyama K
Cancer; 1997 Apr; 79(8):1552-60. PubMed ID: 9118038
[TBL] [Abstract][Full Text] [Related]
2. Malignancy: Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alpha.
Hayashi S; Iwama H; Yahata N; Ando K; Ohyashiki JH; Ohyashiki K
Hematology; 1999; 4(1):1-10. PubMed ID: 11399549
[TBL] [Abstract][Full Text] [Related]
3. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Engelhardt M; Ozkaynak MF; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore MA
Leukemia; 1998 Jan; 12(1):13-24. PubMed ID: 9436916
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.
Ohyashiki K; Ohyashiki JH; Iwama H; Hayashi S; Shay JW; Toyama K
Leukemia; 1997 Feb; 11(2):190-4. PubMed ID: 9009079
[TBL] [Abstract][Full Text] [Related]
6. Telomere dynamics and genetic instability in disease progression of chronic myeloid leukemia.
Ohyashiki K; Iwama H; Tauchi T; Shimamoto T; Hayashi S; Ando K; Kawakubo K; Ohyashiki JH
Leuk Lymphoma; 2000 Dec; 40(1-2):49-56. PubMed ID: 11426628
[TBL] [Abstract][Full Text] [Related]
7. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
[TBL] [Abstract][Full Text] [Related]
8. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Rios MB; Majlis A; Keating M; Freireich EJ; Kantarjian H
J Clin Oncol; 1998 Oct; 16(10):3279-85. PubMed ID: 9779702
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.
Brümmendorf TH; Holyoake TL; Rufer N; Barnett MJ; Schulzer M; Eaves CJ; Eaves AC; Lansdorp PM
Blood; 2000 Mar; 95(6):1883-90. PubMed ID: 10706851
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
12. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
[TBL] [Abstract][Full Text] [Related]
13. Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.
Boultwood J; Peniket A; Watkins F; Shepherd P; McGale P; Richards S; Fidler C; Littlewood TJ; Wainscoat JS
Blood; 2000 Jul; 96(1):358-61. PubMed ID: 10891474
[TBL] [Abstract][Full Text] [Related]
14. Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
Boultwood J; Fidler C; Shepherd P; Watkins F; Snowball J; Haynes S; Kusec R; Gaiger A; Littlewood TJ; Peniket AJ; Wainscoat JS
Am J Hematol; 1999 May; 61(1):5-9. PubMed ID: 10331504
[TBL] [Abstract][Full Text] [Related]
15. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
[TBL] [Abstract][Full Text] [Related]
16. Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia.
Samassekou O; Malina A; Hébert J; Yan J
J Hematol Oncol; 2013 Apr; 6():26. PubMed ID: 23547895
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
O'Brien S; Talpaz M; Cortes J; Shan J; Giles FJ; Faderl S; Thomas D; Garcia-Manero G; Mallard S; Beth M; Koller C; Kornblau S; Andreeff M; Murgo A; Keating M; Kantarjian HM
Cancer; 2002 Apr; 94(7):2024-32. PubMed ID: 11932905
[TBL] [Abstract][Full Text] [Related]
18. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
19. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
Itoh T; Tamura S; Takemoto Y; Kakishita E
Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
[TBL] [Abstract][Full Text] [Related]
20. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
